Related Experiment Video
Updated: Jul 8, 2026

Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart
Published on: September 28, 2016
Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy
M Shimoyama1, D Hayashi, E Takimoto
1Department of Cardiovascular Medicine, University of Tokyo, Graduate School of Medicine, and the Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Insights
Calcineurin activation drives cardiac hypertrophy in response to pressure overload. Inhibiting calcineurin with FK506 prevents this hypertrophy, suggesting a key role for this signaling pathway in heart adaptation.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Cardiac hypertrophy is an adaptive response to hemodynamic overload.
- The precise mechanisms by which mechanical load induces cardiac hypertrophy are not fully understood.
- Recent findings suggest calcineurin, a calcium-dependent phosphatase, mediates cardiac hypertrophy.
Purpose of the Study:
- To investigate the role of calcineurin in pressure overload-induced cardiac hypertrophy.
- To determine if calcineurin activation is a critical factor in the development of cardiac hypertrophy.
Main Methods:
- Inducing pressure overload in rats via abdominal aorta constriction.
- Measuring calcineurin activity in cardiac tissue.
- Administering FK506, a calcineurin inhibitor, to assess its effects.
- Evaluating cardiac hypertrophy, fibrosis, and gene expression changes.
Main Results:
- Pressure overload increased calcineurin activity and induced cardiac hypertrophy and gene reprogramming.
- FK506 treatment inhibited calcineurin activation and prevented cardiac hypertrophy and fibrosis.
- FK506 did not alter hemodynamic parameters.
- Load-induced expression of immediate-early-response and fetal genes was suppressed by FK506.
Conclusions:
- The calcineurin signaling pathway is pivotal in load-induced cardiac hypertrophy.
- Targeting calcineurin may offer a novel pharmacological strategy for preventing cardiac hypertrophy.
Background:
Cardiac hypertrophy is a fundamental adaptive response to hemodynamic overload; how mechanical load induces cardiac hypertrophy, however, remains elusive. It was recently reported that activation of a calcium-dependent phosphatase, calcineurin, induces cardiac hypertrophy. In the present study, we examined whether calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy.
Methods And Results:
Pressure overload produced by constriction of the abdominal aorta increased the activity of calcineurin in the rat heart and induced cardiac hypertrophy, including reprogramming of gene expression. Treatment of rats with a calcineurin inhibitor, FK506, inhibited the activation of calcineurin and prevented the pressure overload-induced cardiac hypertrophy and fibrosis without change of hemodynamic parameters. Load-induced expression of immediate-early-response genes and fetal genes was also suppressed by the FK506 treatment.
Conclusions:
The present results suggest that the calcineurin signaling pathway plays a pivotal role in load-induced cardiac hypertrophy and may pave the way for a novel pharmacological approach to prevent cardiac hypertrophy.
Related Concept Videos
Pathophysiology of Cardiac Performance
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management

